Computational Approach for Combinatorial Library Design Journal club-1 Sushil Kumar Singh IBAB, Bangalore.

Slides:



Advertisements
Similar presentations
JKlustor clustering chemical libraries presented by … maintained by Miklós Vargyas Last update: 25 March 2010.
Advertisements

ChemAxon in 3D Gábor Imre, Adrián Kalászi and Miklós Vargyas Solutions for Cheminformatics.
1 Miklós Vargyas May, 2005 Compound Library Annotation.
Analysis of High-Throughput Screening Data C371 Fall 2004.
What have we learnt about using HT screening as a source of agrochemical leads? John Delaney.
3D Molecular Structures C371 Fall Morgan Algorithm (Leach & Gillet, p. 8)
A Multiobjective Approach to Combinatorial Library Design Val Gillet University of Sheffield, UK.
PharmaMiner: Geometric Mining of Pharmacophores 1.
Jürgen Sühnel Institute of Molecular Biotechnology, Jena Centre for Bioinformatics Jena / Germany Supplementary Material:
GraphSig: Mining Significant Substructures in Compound Libraries 1.
Chemical Diversity Qualify and/or quantify the extent of variety within a set of compounds. Try to define the extent of chemical space. In combinatorial.
1 PharmID: A New Algorithm for Pharmacophore Identification Stan Young Jun Feng and Ashish Sanil NISSMPDM 3 June 2005.
High Performance Dimension Reduction and Visualization for Large High-dimensional Data Analysis Jong Youl Choi, Seung-Hee Bae, Judy Qiu, and Geoffrey Fox.
Establishing a Successful Virtual Screening Process Stephen Pickett Roche Discovery Welwyn.
Faculty of Computer Science © 2006 CMPUT 605February 04, 2008 Novel Approaches for Small Bio-molecule Classification and Structural Similarity Search Karakoc.
Jeffery Loo NLM Associate Fellow ’03 – ’05 chemicalinformaticsforlibraries.
Summary Molecular surfaces QM properties presented on surface Compound screening Pattern matching on surfaces Martin Swain Critical features Dave Whitley.
Luddite: An Information Theoretic Library Design Tool Jennifer L. Miller, Erin K. Bradley, and Steven L. Teig July 18, 2002.
Quantitative Structure-Activity Relationships (QSAR) Comparative Molecular Field Analysis (CoMFA) Gijs Schaftenaar.
Summary Protein design seeks to find amino acid sequences which stably fold into specific 3-D structures. Modeling the inherent flexibility of the protein.
Bioinformatics IV Quantitative Structure-Activity Relationships (QSAR) and Comparative Molecular Field Analysis (CoMFA) Martin Ott.
2DS01 Statistics 2 for Chemical Engineering lecture 5.
1 BrainWave Biosolutions Limited Accelerating Life Science Research through Technology.
RAPID: Randomized Pharmacophore Identification for Drug Design PW Finn, LE Kavraki, JC Latombe, R Motwani, C Shelton, S Venkatasubramanian, A Yao Presented.
1 Chemical Structure Representation and Search Systems Lecture 6. Nov 18, 2003 John Barnard Barnard Chemical Information Ltd Chemical Informatics Software.
Predicting Highly Connected Proteins in PIN using QSAR Art Cherkasov Apr 14, 2011 UBC / VGH THE UNIVERSITY OF BRITISH COLUMBIA.
Pharmacophore and FTrees
Drug Design Process Discovery Phase. Tripos Software n SYBYL & its modules SYBYL, Concord, MOLCAD, SiteId, Advanced Computation, GASP, DISCOtech, HQSAR,
Computational Techniques in Support of Drug Discovery October 2, 2002 Jeffrey Wolbach, Ph. D.
Cédric Notredame (30/08/2015) Chemoinformatics And Bioinformatics Cédric Notredame Molecular Biology Bioinformatics Chemoinformatics Chemistry.
Computer-Assisted Drug Design (1) i)Random Screening ii)Lead Development and Optimization using Multivariate Statistical Analyses. iii)Lead Generation.
Molecular Descriptors
Combinatorial Chemistry and Library Design
Topological Summaries: Using Graphs for Chemical Searching and Mining Graphs are a flexible & unifying model Scalable similarity searches through novel.
Similarity Methods C371 Fall 2004.
Leiden University. The university to discover. Enhancing Search Space Diversity in Multi-Objective Evolutionary Drug Molecule Design using Niching 1. Leiden.
VAMOS Visualization of Accessible Molecular Space A new compound filtering and selection interface Spotfire User Conference - Europe - May , 2003.
A genetic algorithm for structure based de-novo design Scott C.-H. Pegg, Jose J. Haresco & Irwin D. Kuntz February 21, 2006.
EXPLORING CHEMICAL SPACE FOR DRUG DISCOVERY Daniel Svozil Laboratory of Informatics and Chemistry.
Fusing database rankings in similarity-based virtual screening Peter Willett, University of Sheffield.
Daniel Brown. D9.1 Discuss the use of a compound library in drug design. Traditionally, a large collection of related compounds are synthesized individually.
Genomics Research Institute University of Cincinnati Compound Library Wm. L. Seibel January 10, 2007.
Designing a Tri-Peptide based HIV-1 protease inhibitor Presented by, Sushil Kumar Singh IBAB,Bangalore Submitted to Dr. Indira Ghosh AstraZeneca India.
Faculté de Chimie, ULP, Strasbourg, FRANCE
Use of Machine Learning in Chemoinformatics Irene Kouskoumvekaki Associate Professor December 12th, 2012 Biological Sequence Analysis course.
Drug Discovery Process Massimiliano Beltramo, PhD.
Ligand-based drug discovery No a priori knowledge of the receptor What information can we get from a few active compounds.
SAR vs QSAR or “is QSAR different from SAR”
QSAR Study of HIV Protease Inhibitors Using Neural Network and Genetic Algorithm Akmal Aulia, 1 Sunil Kumar, 2 Rajni Garg, * 3 A. Srinivas Reddy, 4 1 Computational.
SimFinder: A Unique Topology- based Approach to Similarity Searching 1.
Virtual Screening C371 Fall INTRODUCTION Virtual screening – Computational or in silico analog of biological screening –Score, rank, and/or filter.
Selecting Diverse Sets of Compounds C371 Fall 2004.
Computer-aided drug discovery (CADD)/design methods have played a major role in the development of therapeutically important small molecules for several.
PharmaMiner: Geometric Mining of Pharmacophores 1.
Catalyst TM What is Catalyst TM ? Structural databases Designing structural databases Generating conformational models Building multi-conformer databases.
Design of a Compound Screening Collection Gavin Harper Cheminformatics, Stevenage.
Use of Machine Learning in Chemoinformatics
4. Molecular Similarity. 2 Similarity and Searching Historical Progression Similarity Measures Fingerprint Construction “Pathological” Cases MinMax- Counts.
Bioinformatics in Drug Design and Discovery Unit 2.
Identification of structurally diverse Growth Hormone Secretagogue (GHS) agonists by virtual screening and structure-activity relationship analysis of.
Reaxys – The Highlights. Slide 2 What is Reaxys? A brand new workflow solution for research chemists and scientists from related disciplines An extensive.
Julia Salas CS379a Aim of the Study To determine distinguishing features of orally administered drugs –Physical and structural features probed.
Natural products from plants
Page 1 Computer-aided Drug Design —Profacgen. Page 2 The most fundamental goal in the drug design process is to determine whether a given compound will.
Toxicity vs CHEMICAL space
An Introduction to Medicinal Chemistry 3/e COMBINATORIAL CHEMISTRY
Drug Discovery is a Numbers Game
APPLICATIONS OF BIOINFORMATICS IN DRUG DISCOVERY
Virtual Screening.
Statistics 2 for Chemical Engineering lecture 5
Presentation transcript:

Computational Approach for Combinatorial Library Design Journal club-1 Sushil Kumar Singh IBAB, Bangalore

Chemical Synthesis of compounds Traditional Synthesis A + B → AB(1 chemist=50 compounds/Year) Combinatorial Synthesis A Am B Bn Total No of Compounds m*n ,000 compounds per experiment.

Challenges Do these new technology will lead to better drugs faster ? Can we make and test every thing ? So, Lead discovery and optimization is not a just game of numbers and it requires intelligent design choice.

Library design method Setting up library with maximum diversity. Diverse libraries - Lead generation libraries for screening against no of targets A structurally diverse library should cover biological activity space as well.

Requirements for measuring diversity Molecular descriptors to define structure space 1D- mw, log p(o/w) 2D- surface area, flexibility. 3D-Pharmacophore- collections of atoms/functional group & their orientations. Way to quantify the (dis)similarity of compounds. Subset selection algorithm to ensure full coverage of structural space.

Descriptors selection and validation On comparing 2-D and 3-D descriptors, it was found that 2-D descriptors were more effective and more accurate for structure search. 2-D descriptors consist majority of substructures present in the molecule. 3-D pharmacophore encodes information about only three atoms or group at a time with limited no of conformations; but important for biological activity of molecule.

Descriptors and chemical space While choosing descriptors Avoid correlated descriptors. Choose those which can add maximum biological activity to library. Every descriptor adds a dimension to chemical space. A large no of descriptors is often reduce to smaller no using PCA.

Quantifications of (dis)similarity of compounds Tanimoto coefficient= bc/(b1+b2 – bc) for 2-D molecular similarity by comparing bit strings. (e.g MDL information systems.) Fingerprints like Daylight, ISIS etc. also compare 2-D similarity. 3-D pharmacophore similarity also calculated by on the basis of bit string in 2D case.

Other methods Distance-based- MaxMin: chooses points to maximize the smaller near-neighbor distance in design set. Grid/Cell based BCUT: Combination of 2-D and 3-D descriptor; commonly use in QSAR. 3-D pharmacophore: maximizing diversity - rigid and flexible conformers with multiple energy.

Lead optimization After library generation → Lead optimization -before optimizing a hit, do activity analysis of different regions of a molecule with small no. of individual molecule.

Conclusion Library design depends Design algorithm and Property space So Comparing library is a difficult – different design with different property space. It requires Combination of structural diversity calculations. Experience. Good medicinal chemical intuition.

Thank You